Related Experiment Videos
[Cytogenetic changes in prostatic carcinoma]
G Sauter1, L Bubendorf, H Moch
1Institut für Pathologie, Universitätsspital Basel.
Abstract:
Development and progression of tumors is driven by a malfunction of specific genes. Although prostate cancer is one of the most frequent tumors, little is known about the genes involved. Cytogenetic and molecular examinations have shown that chromosomal deletions most frequently involve 7q, 8p, 10q, 13q, 16q, 17p and the Y chromosome. These loci may carry tumor suppressor genes with relevance for prostate cancer. DNA sequence copy number gains were most frequently observed at chromosomes 7, 8q, and 11q. These regions may carry currently unknown oncogenes. There is increasing evidence for a clinical relevance of genetic alterations. Polysomies of several chromosomes were shown to be associated with poor prognosis of prostate cancer patients. Androgen receptor amplification can be found in hormone-refractory carcinomas which may respond to total androgen blockage. For the future it is hoped that the identification of the genes involved in prostate cancer and the determination of their function could allow for significant improvements of treatment strategies for prostate cancer patients.
Insights
Genetic alterations in prostate cancer, including deletions and gains on specific chromosomes, are linked to tumor development. Identifying these genes could improve treatment strategies for this common cancer.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Context:
- Prostate cancer is a frequent malignancy with incompletely understood genetic underpinnings.
- Tumorigenesis is driven by genetic malfunctions, necessitating the identification of key genes in prostate cancer.
Purpose:
- To review current knowledge on genetic alterations in prostate cancer.
- To highlight chromosomal regions frequently affected by deletions and gains in prostate tumors.
- To discuss the clinical relevance of identified genetic changes.
Summary:
- Cytogenetic and molecular analyses reveal frequent chromosomal deletions at 7q, 8p, 10q, 13q, 16q, 17p, and the Y chromosome, potentially harboring tumor suppressor genes.
- Recurrent DNA copy number gains are observed on chromosomes 7, 8q, and 11q, suggesting the presence of novel oncogenes.
- Specific genetic alterations, such as polysomies and androgen receptor amplification, correlate with poor prognosis and treatment resistance in prostate cancer.
Impact:
- Understanding these genetic alterations provides insights into prostate cancer development and progression.
- Identification of specific genes involved in prostate cancer can pave the way for targeted therapies.
- This knowledge is crucial for developing improved diagnostic and prognostic tools for prostate cancer patients.